Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction

Jin Li, Shukui Qin, Jianming Xu, +31

Journal of Clinical Oncology

A comprehensive genome‐wide analysis of long noncoding RNA expression profile in hepatocellular carcinoma

Hongxia Cui, Yunxing Zhang, Qiujie Zhang, +3

Cancer Medicine

<scp>MALAT</scp>1 induces tongue cancer cells' <scp>EMT</scp> and inhibits apoptosis through Wnt/β‐catenin signaling pathway

Jun Liang, Lizhong Liang, Kexiong Ouyang, +2

Journal of Oral Pathology and Medicine

<scp>FOXM</scp>1 mediates resistance to docetaxel in gastric cancer <i>via</i> up‐regulating Stathmin

Xiaoxiao Li, Ruyong Yao, Yue Lu, +5

Journal of Cellular and Molecular Medicine

PathologyCancer BiologyMicrotubule DynamicsTumor BiologyMolecular Pharmacology +16

Genetic Polymorphism of GSTP1: Prediction of Clinical Outcome to Oxaliplatin/5-FU-based Chemotherapy in Advanced Gastric Cancer

Qingfang Li, Ruyong Yao, Kewei Liu, +3

Journal of Korean Medical Science

Advanced Gastric CancerGeneticsGenetic EpidemiologyGastroenterologyPathology +15

The combination of ERCC1 and XRCC1 gene polymorphisms better predicts clinical outcome to oxaliplatin-based chemotherapy in metastatic colorectal cancer

Jun Liang, Tao Jiang, Ruyong Yao, +3

Cancer Chemotherapy and Pharmacology

Xrcc1 Gene PolymorphismsMedicineOxaliplatin-based ChemotherapyColorectal CancerPathology +6

Synthesis and Biological Evaluation of Novel Folic Acid Receptor-Targeted, β-Cyclodextrin-Based Drug Complexes for Cancer Treatment

Juan-Juan Yin, Sonali Sharma, Stepan Shumyak, +19

PLoS ONE

Forkhead box transcription factor 1 expression in gastric cancer: FOXM1 is a poor prognostic factor and mediates resistance to docetaxel

Xiaoxiao Li, Wensheng Qiu, Bin Liu, +4

Journal of Translational Medicine

Overexpression of metabolic markers HK1 and PKM2 contributes to lymphatic metastasis and adverse prognosis in Chinese gastric cancer.

Yunshu Gao, Dongyun Xu, Guanzhen Yu, +1

PubMed

ImmunologyPathologyCancer BiologyTumor BiologyHexokinase 1 +15

Aprepitant triple therapy for the prevention of chemotherapy-induced nausea and vomiting following high-dose cisplatin in Chinese patients: a randomized, double-blind, placebo-controlled phase III trial

Zhihuang Hu, Ying Cheng, Hongyu Zhang, +16

Supportive Care in Cancer

Aprepitant Triple TherapyOncologyMedicineMetronomic TherapyPharmacotherapy +4